These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 38702933)

  • 81. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
    Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS
    Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Age-dependent neurodegeneration and neuroinflammation in a genetic A30P/A53T double-mutated α-synuclein mouse model of Parkinson's disease.
    Rauschenberger L; Behnke J; Grotemeyer A; Knorr S; Volkmann J; Ip CW
    Neurobiol Dis; 2022 Sep; 171():105798. PubMed ID: 35750147
    [TBL] [Abstract][Full Text] [Related]  

  • 83. From inflammasome to Parkinson's disease: Does the NLRP3 inflammasome facilitate exosome secretion and exosomal alpha-synuclein transmission in Parkinson's disease?
    Si XL; Fang YJ; Li LF; Gu LY; Yin XZ; Jun-Tian ; Yan YP; Pu JL; Zhang BR
    Exp Neurol; 2021 Feb; 336():113525. PubMed ID: 33161049
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Papaverine inhibits α-synuclein aggregation by modulating neuroinflammation and matrix metalloproteinase-3 expression in the subacute MPTP/P mouse model of Parkinson's disease.
    Leem YH; Park JS; Park JE; Kim DY; Kang JL; Kim HS
    Biomed Pharmacother; 2020 Oct; 130():110576. PubMed ID: 32768884
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Saposin C, Key Regulator in the Alpha-Synuclein Degradation Mediated by Lysosome.
    Ruz C; Barrero FJ; Pelegrina J; Bandrés-Ciga S; Vives F; Duran R
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233303
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice.
    Deng I; Corrigan F; Garg S; Zhou XF; Bobrovskaya L
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299000
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The lysosomal enzyme alpha-Galactosidase A is deficient in Parkinson's disease brain in association with the pathologic accumulation of alpha-synuclein.
    Nelson MP; Boutin M; Tse TE; Lu H; Haley ED; Ouyang X; Zhang J; Auray-Blais C; Shacka JJ
    Neurobiol Dis; 2018 Feb; 110():68-81. PubMed ID: 29196214
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Suppression of the JAK/STAT pathway inhibits neuroinflammation in the line 61-PFF mouse model of Parkinson's disease.
    Hong H; Wang Y; Menard M; Buckley JA; Zhou L; Volpicelli-Daley L; Standaert DG; Qin H; Benveniste EN
    J Neuroinflammation; 2024 Sep; 21(1):216. PubMed ID: 39218899
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Involvement of Abnormal p-α-syn Accumulation and TLR2-Mediated Inflammation of Schwann Cells in Enteric Autonomic Nerve Dysfunction of Parkinson's Disease: an Animal Model Study.
    Jiang W; Cheng Y; Wang Y; Wu J; Rong Z; Sun L; Zhou Y; Zhang K
    Mol Neurobiol; 2023 Aug; 60(8):4738-4752. PubMed ID: 37148524
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Transmission of α-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: another mechanism for initiation and progression of Parkinson's disease?
    Matsumoto J; Stewart T; Sheng L; Li N; Bullock K; Song N; Shi M; Banks WA; Zhang J
    Acta Neuropathol Commun; 2017 Sep; 5(1):71. PubMed ID: 28903781
    [TBL] [Abstract][Full Text] [Related]  

  • 92. α-Synuclein aggregation and transmission in Parkinson's disease: a link to mitochondria and lysosome.
    Wang R; Sun H; Ren H; Wang G
    Sci China Life Sci; 2020 Dec; 63(12):1850-1859. PubMed ID: 32681494
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Brain iron enrichment attenuates α-synuclein spreading after injection of preformed fibrils.
    Dauer Née Joppe K; Tatenhorst L; Caldi Gomes L; Zhang S; Parvaz M; Carboni E; Roser AE; El DeBakey H; Bähr M; Vogel-Mikuš K; Wang Ip C; Becker S; Zweckstetter M; Lingor P
    J Neurochem; 2021 Nov; 159(3):554-573. PubMed ID: 34176164
    [TBL] [Abstract][Full Text] [Related]  

  • 94. MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease.
    Zhou Y; Lu M; Du RH; Qiao C; Jiang CY; Zhang KZ; Ding JH; Hu G
    Mol Neurodegener; 2016 Apr; 11():28. PubMed ID: 27084336
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Down-regulation of DJ-1 Augments Neuroinflammation via Nrf2/Trx1/NLRP3 Axis in MPTP-induced Parkinson's Disease Mouse Model.
    Ji YJ; Wang HL; Yin BL; Ren XY
    Neuroscience; 2020 Aug; 442():253-263. PubMed ID: 32526245
    [TBL] [Abstract][Full Text] [Related]  

  • 96. RILP regulates vacuolar ATPase through interaction with the V1G1 subunit.
    De Luca M; Cogli L; Progida C; Nisi V; Pascolutti R; Sigismund S; Di Fiore PP; Bucci C
    J Cell Sci; 2014 Jun; 127(Pt 12):2697-708. PubMed ID: 24762812
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting α-synuclein abnormalities in the substantia nigra.
    Heng Y; Zhang QS; Mu Z; Hu JF; Yuan YH; Chen NH
    Toxicol Lett; 2016 Jan; 243():7-21. PubMed ID: 26723869
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Neuropathology in an α-synuclein preformed fibril mouse model occurs independent of the Parkinson's disease-linked lysosomal ATP13A2 protein.
    Massari CM; Dues DJ; Bergsma A; Sipple K; Frye M; Williams ET; Moore DJ
    Neurobiol Dis; 2024 Nov; 202():106701. PubMed ID: 39406291
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Targeted degradation of ⍺-synuclein aggregates in Parkinson's disease using the AUTOTAC technology.
    Lee J; Sung KW; Bae EJ; Yoon D; Kim D; Lee JS; Park DH; Park DY; Mun SR; Kwon SC; Kim HY; Min JO; Lee SJ; Suh YH; Kwon YT
    Mol Neurodegener; 2023 Jun; 18(1):41. PubMed ID: 37355598
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Analysis of m6A modification regulators in the substantia nigra and striatum of MPTP-induced Parkinson's disease mice.
    Yu Z; Huang L; Xia Y; Cheng S; Yang C; Chen C; Zou Z; Wang X; Tian X; Jiang X; Zhou L
    Neurosci Lett; 2022 Nov; 791():136907. PubMed ID: 36209975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.